Home > Medical Reference > Patient Education

Ask Our Experts

Get answers to your specific medical questions from UM Medical Center experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Our Doctors

Patient Success Stories

Speciality Services

Podcasts

Scleroderma

Description

An in-depth report on the causes, diagnosis, treatment, and prevention of scleroderma.


Alternative Names

Systemic sclerosis


Introduction

The name scleroderma comes from the Greek words skleros , which means hard, and derma , which means skin. The disease is categorized as a rheumatologic disorder because it affects the connective tissues in the body. Scleroderma is a rare disease marked by the following:

Patients with scleroderma may develop either a localized or a systemic (body-wide) form of the disease.

Localized Scleroderma

Localized scleroderma usually affects only the skin on the hands and face. Its course is very slow and it rarely, if ever, becomes systemic or causes serious complications. There are two main forms of localized scleroderma: morphea and linear scleroderma.

Morphea Scleroderma . In morphea scleroderma, patches of hard skin form and can last for years. Eventually, however, they may improve or even disappear. There is less than a 1% chance that this disorder will progress to systemic scleroderma.

Linear Scleroderma . Linear scleroderma causes bands of hard skin across the face or on a single arm or leg. Linear scleroderma may also involve muscle or bone. In rare cases, if this type of scleroderma affects children or young adults, it may interfere with growth and cause severe deformities in the arms and legs.

Systemic Scleroderma

Systemic scleroderma is also called systemic sclerosis. This form of the disease may affect the organs of the body, large areas of the skin, or both. This form of scleroderma has two main types: limited and diffuse scleroderma. Both forms are progressive, although most often the course in either one is slow.

Limited Scleroderma (also called CREST Syndrome). Limited scleroderma is a progressive disorder. It is classified as a systemic disease because its effects can be widespread. It generally differs from diffuse scleroderma in the following ways:

Limited scleroderma is commonly referred to by the acronym CREST, whose letters are the first initials of characteristics that are usually found in this syndrome:

In general, people with limited scleroderma experience a long duration of Raynaud's phenomenon before they develop any of the other symptoms mentioned above. It should be noted that one or more of the CREST conditions can also occur in other forms of scleroderma.

Diffuse Scleroderma. Diffuse scleroderma, the other systemic sclerosis, has the following characteristics:


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com